{"nct_id":"NCT01274559","title":"Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)","status":"TERMINATED","status_verified_date":"2024-05","start_date":"2011-03-01","start_date_type":"ACTUAL","primary_completion_date":"2013-02-26","primary_completion_date_type":"ACTUAL","completion_date":"2013-02-26","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}